Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Common Equity (2021 - 2025)

OneMedNet has reported Common Equity over the past 5 years, most recently at -$3.0 million for Q4 2025.

  • Quarterly Common Equity rose 81.41% to -$3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Dec 2025, up 81.41% year-over-year, with the annual reading at -$3.0 million for FY2025, 81.41% up from the prior year.
  • Common Equity was -$3.0 million for Q4 2025 at OneMedNet, up from -$3.9 million in the prior quarter.
  • Over five years, Common Equity peaked at -$3.0 million in Q4 2025 and troughed at -$47.8 million in Q3 2023.
  • The 5-year median for Common Equity is -$14.3 million (2024), against an average of -$16.4 million.
  • Year-over-year, Common Equity crashed 490.49% in 2023 and then skyrocketed 81.41% in 2025.
  • A 5-year view of Common Equity shows it stood at -$7.1 million in 2021, then crashed by 273.78% to -$26.4 million in 2022, then skyrocketed by 49.0% to -$13.4 million in 2023, then decreased by 18.66% to -$16.0 million in 2024, then skyrocketed by 81.41% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Common Equity are -$3.0 million (Q4 2025), -$3.9 million (Q3 2025), and -$3.8 million (Q2 2025).